» Articles » PMID: 17493125

Differences in Trans-stimulated Chloroquine Efflux Kinetics Are Linked to PfCRT in Plasmodium Falciparum

Overview
Journal Mol Microbiol
Date 2007 May 12
PMID 17493125
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism underpinning chloroquine drug resistance in the human malarial parasite Plasmodium falciparum has remained controversial. Currently discussed models include a carrier or a channel for chloroquine, the former actively expelling the drug, the latter facilitating its passive diffusion, out of the parasite's food vacuole, where chloroquine accumulates and inhibits haem detoxification. Here we have challenged both models using an established trans-stimulation efflux protocol. While carriers may demonstrate trans-stimulation, channels do not. Our data reveal that extracellular chloroquine stimulates chloroquine efflux in the presence and absence of metabolic energy in both chloroquine-sensitive and -resistant parasites, resulting in a hyperbolic increase in the apparent initial efflux rates as the concentration of external chloroquine increases. In the absence of metabolic energy, the apparent initial efflux rates were comparable in both parasites. Significant differences were only observed in the presence of metabolic energy, where consistently higher apparent initial efflux rates were found in chloroquine-resistant parasites. As trans-stimulation is characteristic of a carrier, and not a channel, we interpret our data in favour of a carrier for chloroquine being present in both chloroquine-sensitive and -resistant parasites, however, with different transport modalities.

Citing Articles

Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso.

Tarama C, Sore H, Siribie M, Debe S, Kinda R, Ganou A Malar J. 2023; 22(1):213.

PMID: 37474966 PMC: 10360335. DOI: 10.1186/s12936-023-04645-9.


pH-dependence of the Plasmodium falciparum chloroquine resistance transporter is linked to the transport cycle.

Berger F, Gomez G, Sanchez C, Posch B, Planelles G, Sohraby F Nat Commun. 2023; 14(1):4234.

PMID: 37454114 PMC: 10349806. DOI: 10.1038/s41467-023-39969-2.


Structures of Chloroquine Resistance Transporter (PfCRT) Isoforms and Their Interactions with Chloroquine.

Willems A, Kalaw A, Ecer A, Kotwal A, Roepe L, Roepe P Biochemistry. 2023; 62(5):1093-1110.

PMID: 36800498 PMC: 10950298. DOI: 10.1021/acs.biochem.2c00669.


Pharmacophore-Based Discovery of Substrates of a Novel Drug/Proton-Antiporter in the Human Brain Endothelial hCMEC/D3 Cell Line.

Smirnova M, Goracci L, Cruciani G, Federici L, Decleves X, Chapy H Pharmaceutics. 2022; 14(2).

PMID: 35213988 PMC: 8875908. DOI: 10.3390/pharmaceutics14020255.


Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery.

Adigo Shibeshi M, Kifle Z, Atnafie S Infect Drug Resist. 2020; 13:4047-4060.

PMID: 33204122 PMC: 7666977. DOI: 10.2147/IDR.S279433.


References
1.
Cabantchik Z, Ginsburg H . Transport of uridine in human red blood cells. Demonstration of a simple carrier-mediated process. J Gen Physiol. 1977; 69(1):75-96. PMC: 2215042. DOI: 10.1085/jgp.69.1.75. View

2.
Keynes R, Lewis P . Determination of the ionic exchange during nervous activity by activation analysis. Nature. 1950; 165(4203):809-10. DOI: 10.1038/165809a0. View

3.
Ursos L, Roepe P . Chloroquine resistance in the malarial parasite, Plasmodium falciparum. Med Res Rev. 2002; 22(5):465-91. DOI: 10.1002/med.10016. View

4.
Sanchez C, McLean J, Rohrbach P, Fidock D, Stein W, Lanzer M . Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry. 2005; 44(29):9862-70. DOI: 10.1021/bi050061f. View

5.
Yayon A, Cabantchik Z, Ginsburg H . Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 1984; 3(11):2695-700. PMC: 557751. DOI: 10.1002/j.1460-2075.1984.tb02195.x. View